DNMT1 Overexpression Predicting Gastric Carcinogenesis, Subsequent Progression and Prognosis: A Meta and Bioinformatic Analysis

Oncotarget - United States
doi 10.18632/oncotarget.21480
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Clinicopathological and Prognostic Significance of HMGA2 Overexpression in Gastric Cancer: A Meta-Analysis

Oncotarget
Oncology
2017English

NEDD9 Overexpression Predicts Poor Prognosis in Solid Cancers: A Meta-Analysis

OncoTargets and Therapy
OncologyPharmacology
2019English

ZNF418 Overexpression Protects Against Gastric Carcinoma and Prompts a Good Prognosis

OncoTargets and Therapy
OncologyPharmacology
2018English

Clinical, Cellular, and Bioinformatic Analyses Reveal Involvement of WRAP53 Overexpression in Carcinogenesis of Lung Adenocarcinoma

Tumor Biology
MedicineCancer Research
2017English

Overexpression of Fn14 in Gliomas: Tumor Progression and Poor Prognosis

Future Oncology
MedicineCancer ResearchOncology
2018English

BMI1 and Mel-18 Oppositely Regulate Carcinogenesis and Progression of Gastric Cancer

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2010English

Association of Ezrin Expression With the Progression and Prognosis of Gastrointestinal Cancer: A Meta-Analysis

Oncotarget
Oncology
2017English

Overexpression of Forkhead Box M1 and Urokinase‑type Plasminogen Activator in Gastric Cancer Is Associated With Cancer Progression and Poor Prognosis

Oncology Letters
Cancer ResearchOncology
2017English

BCYRN1 Is Correlated With Progression and Prognosis in Gastric Cancer

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy